Scolaris Content Display Scolaris Content Display

Enzyme replacement therapy for late‐onset Pompe disease

This is not the most recent version

view the current version 12 December 2023

References

Additional references

Amato 2011

Amato AA, Leep Hunderfund AN, Selcen D, Keegan BM. A 49‐year‐old woman with progressive shortness of breath. Neurology 2011;76(9):830‐6.

Ausems 1999

Ausems MG, Verbiest J, Hermans MP, Kroos MA, Beemer FA, Wokke JH, et al. Frequency of glycogen storage disease type II in the Netherlands: implications for diagnosis and genetic counselling. European Journal of Human Genetics 1999;7(6):713‐6.

Beltran Papsdorf 2014

Beltran Papsdorf TB, Howard JF, Chahin N. Pearls & Oy‐sters: clues to the diagnosis of adult‐onset acid maltase deficiency. Neurology 2014;82(9):e73‐5.

Cohen 1960

Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960;20(1):37‐46.

Deeks 2011

Deeks J, Higgins J, Altman D, editor(s). Chapter 9: Analysing data and undertaking meta‐analysis. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

EMA 2011

EMA 2011. Annex 1. Summary of product characteristics. www.ema.europa.eu/docs/en_GB/document_library/EPAR_‐_Product_Information/human/000636/WC500032125.pdf (accessed 13 July 2017).

Hagemans 2005

Hagemans ML, Winkel LP, Van Doorn PA, Hop WJ, Loonen MC, Reuser AJ, et al. Clinical manifestation and natural course of late‐onset Pompe's disease in 54 Dutch patients. Brain 2005;128(Pt 3):671‐7.

Higgins 2003

Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327(7414):557‐60.

Higgins 2008

Higgins JP, White IR, Anzures‐Cabrera J. Meta‐analysis of skewed data: combining results reported on log‐transformed or raw scales. Statistics in Medicine2008; Vol. 27, issue 29:6072‐92.

Higgins 2011a

Higgins JP, Altman DG, Sterne JA, editor(s) on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Higgins 2011b

Higgins JP, Deeks JJ, Altman DG, editor(s). Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Hirschorn 2001

Hirschorn R, Reuser AJ. Glycogen storage disease type II: acid alpha‐glucosidase (acid maltase) deficiency. In: Scriver CR, Valle D editor(s). The Metabolic and Molecular Bases of Inherited Disease. 8th Edition. New York (NY): McGraw‐Hill, 2001:3389‐420.

Johnson 2016

Johnson EM, Roberts M, Mozaffar T, Young P, Quartel A, Berger KI. Pulmonary function tests (maximum inspiratory pressure, maximum expiratory pressure, vital capacity, forced vital capacity) predict ventilator use in late‐onset Pompe disease. Neuromuscular Disorders 2016;26(2):136‐45.

Kishnani 2006

Kishnani PS, Hwu WL, Mandel H, Nicolino M, Yong F, Corzo D, et al. A retrospective, multinational, multicenter study on the natural history of infantile‐onset Pompe disease. Journal of Pediatrics 2006;148(5):671‐6.

Kishnani 2013

Kishnani PS, Amartino HM, Lindberg C, Miller TM, Wilson A, Keutzer J, et al. Timing of diagnosis of patients with Pompe disease: data from the Pompe registry. American Journal of Medical Genetics 2013;161A(10):2431‐43.

Mah 2010

Mah CS, Falk DJ, Germain SA, Kelley JS, Lewis MA, Cloutier DA, et al. Gel‐mediated delivery of AAV1 vectors corrects ventilatory function in Pompe mice with established disease. Molecular Therapy 2010;18(13):502‐10.

Mechtler 2012

Mechtler TP, Stary S, Metz TF, De Jesús VR, Greber‐Platzer S, Pollak A, et al. Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria. Lancet 2012;379(9813):335‐41.

Pellegrini 2005

Pellegrini N, Laforet P, Orlikowski D, Pellegrini M, Caillaud C, Eymard B, et al. Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease. European Respiratory Journal 2005;26(6):1024‐31.

Schünemann 2011a

Schünemann HJ, Oxman AD, Higgins JP, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and ‘Summary of findings’ tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Schünemann 2011b

Schünemann HJ, Oxman AD, Vist GE, Higgins JP, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Sterne 2011

Sterne JA, Egger M, Moher D, editor(s). Chapter 10: Addressing reporting biases. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Tein 1996

Tein I. Metabolic myopathies. Seminars in Pediatric Hematology 1996;3(2):59‐98.

van den Hout 2003

van den Hout HM, Hop W, van Diggelen OP, Smeitink JA, Smit GP, Poll‐The BT, et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics 2003;112(2):332‐40.

van der Ploeg 2008

van der Ploeg AT, Reuser AJ. Pompe's disease. Lancet 2008;372(9646):1342‐53.